Quantcast

Aspirin cuts mortality rate in gut cancer – Bayer

July 1, 2005

FRANKFURT (Reuters) – German drug and chemicals group Bayer
cited on Friday a study that showed the active ingredient in
Aspirin lowered the mortality rate in recurring intestinal
cancer.

Taking the drug regularly also lowered recurrence of the
disease by 48 percent, it said in a statement.

Bayer invented the pain and fever drug more than a century
ago.




comments powered by Disqus